Medicine
Zilretta kit
Zilretta kit is a prescription medicine containing Triamcinolone acetonide extended-release injectable suspension for intra-articular use, marketed by Pacira Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store vials in carton.
Key facts
- Active ingredient (INN)
- Triamcinolone acetonide extended-release injectable suspension
- Brand
- Zilretta
- Dosage form
- Kit
- Route
- Intra-articular
- Packs
- 1 kit
- Marketing authorisation holder
- Pacira Pharmaceuticals
- Manufacturer
- Pacira Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store vials in carton.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 6 October 2017
- Identifiers
- RxCUI 1947131, 1947133DailyMed set ID cd5c4673-21f2-4126-9556-da847b3a228bNDC 65250-003Application NDA208845
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 carton * 1 injection, powder, for suspension, extended release in 1 vial, single-dose * 1 injection, solution in 1 vial, single-dose | 65250-003-01 | Pacira Pharmaceuticals | 6 October 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Triamcinolone acetonide extended-release injectable suspension is a prescription medicine indicated as an intra-articular injection for the management of osteoarthritis pain of the knee. It is available as kits for intra-articular use. MedsAcross supplies Triamcinolone acetonide extended-release injectable suspension for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Triamcinolone acetonide extended-release injectable suspensionFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Zilretta prescribing information (Pacira Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Zilretta kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.